SIDT2
Basic information
Region (hg38): 11:117178736-117197445
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SIDT2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 31 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 3 | 2 |
Variants in SIDT2
This is a list of pathogenic ClinVar variants found in the SIDT2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-117179298-T-C | not specified | Uncertain significance (Jul 01, 2024) | ||
11-117179401-G-C | not specified | Uncertain significance (Jun 16, 2023) | ||
11-117181421-G-C | not specified | Uncertain significance (Jun 24, 2022) | ||
11-117181465-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
11-117181488-C-A | not specified | Uncertain significance (Feb 23, 2023) | ||
11-117181503-G-C | not specified | Uncertain significance (Oct 08, 2024) | ||
11-117181807-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
11-117181859-C-T | not specified | Uncertain significance (Dec 02, 2022) | ||
11-117181875-C-T | not specified | Uncertain significance (Oct 20, 2024) | ||
11-117181893-A-C | not specified | Uncertain significance (Oct 17, 2023) | ||
11-117181895-G-A | not specified | Uncertain significance (Oct 03, 2024) | ||
11-117181952-A-G | not specified | Uncertain significance (Apr 17, 2023) | ||
11-117181958-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
11-117182526-A-C | not specified | Uncertain significance (Apr 07, 2022) | ||
11-117182546-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
11-117182567-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
11-117182726-C-G | not specified | Uncertain significance (Jul 25, 2023) | ||
11-117182735-G-T | not specified | Uncertain significance (Jul 05, 2024) | ||
11-117182742-A-G | not specified | Uncertain significance (Jan 11, 2023) | ||
11-117182750-G-A | not specified | Uncertain significance (May 09, 2023) | ||
11-117183779-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
11-117183860-T-G | not specified | Uncertain significance (Jan 02, 2024) | ||
11-117186578-A-G | Benign (Jan 31, 2018) | |||
11-117186613-T-C | not specified | Uncertain significance (Jan 10, 2022) | ||
11-117187382-C-A | not specified | Uncertain significance (Nov 17, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SIDT2 | protein_coding | protein_coding | ENST00000324225 | 26 | 18712 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.20e-10 | 1.00 | 125685 | 0 | 63 | 125748 | 0.000251 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.95 | 389 | 513 | 0.758 | 0.0000316 | 5446 |
Missense in Polyphen | 133 | 234.07 | 0.5682 | 2516 | ||
Synonymous | -1.50 | 243 | 215 | 1.13 | 0.0000141 | 1632 |
Loss of Function | 3.50 | 25 | 52.3 | 0.478 | 0.00000262 | 550 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000904 | 0.000904 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000195 | 0.000193 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000294 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates the translocation of RNA and DNA across the lysosomal membrane during RNA and DNA autophagy (RDA), a process in which RNA or DNA is directly imported into lysosomes in an ATP- dependent manner, and degraded (PubMed:27046251, PubMed:27846365). Involved in the uptake of single-stranded oligonucleotides by living cells, a process called gymnosis (PubMed:28277980). Involved in the uptake of single-stranded oligonucleotides by living cells, a process called gymnosis. In vitro, mediates the uptake of linear DNA more efficiently than that of circular DNA, but exhibits similar uptake efficacy toward RNA and DNA. Binds long double-stranded RNA (dsRNA) (500 - 700 base pairs), but not dsRNA shorter than 100 bp (By similarity). {ECO:0000250|UniProtKB:Q8CIF6, ECO:0000269|PubMed:27046251, ECO:0000269|PubMed:27846365, ECO:0000269|PubMed:28277980}.;
Intolerance Scores
- loftool
- 0.678
- rvis_EVS
- -0.04
- rvis_percentile_EVS
- 50.54
Haploinsufficiency Scores
- pHI
- 0.458
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.463
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.569
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sidt2
- Phenotype
- immune system phenotype; liver/biliary system phenotype; normal phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- cell morphogenesis;type B pancreatic cell development;RNA catabolic process;response to glucose;dsRNA transport;glucose homeostasis;type B pancreatic cell proliferation;RNA transport;regulation of insulin secretion involved in cellular response to glucose stimulus
- Cellular component
- lysosome;lysosomal membrane;plasma membrane;integral component of membrane
- Molecular function
- DNA binding;double-stranded RNA binding;AP-2 adaptor complex binding;AP-1 adaptor complex binding;nucleic acid transmembrane transporter activity;RNA transmembrane transporter activity